TickerFacts.

Mimedx Group, Inc. (MDXG): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$86.11M
As of 2025-12-31
$65.00M
As of 2026-06-30
-3.9%
3-year compound annual growth
-4.9%
5-year compound annual growth
$132.77M2010-12-31: $1.25M2011-12-31: $15.20M2012-12-31: $15.18M2013-12-31: $11.13M2014-12-31: $19.93M2015-12-31: $27.93M2016-12-31: $69.21M2017-12-31: $47.46M2018-12-31: $73.19M2019-12-31: $132.77M2020-12-31: $110.61M2021-12-31: $95.35M2022-12-31: $96.92M2023-12-31: $96.33M2024-12-31: $70.81M2025-12-31: $86.11M$86.11M
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$86.11M+21.6%2026-02-25, Balance as of period end
2024-12-31$70.81M-26.5%2026-02-25, Balance as of period end
2023-12-31$96.33M-0.6%2025-02-26, Balance as of period end
2022-12-31$96.92M+1.6%2024-02-28, Balance as of period end
2021-12-31$95.35M-13.8%2023-02-28, Balance as of period end
2020-12-31$110.61M-16.7%2022-02-28, Balance as of period end
2019-12-31$132.77M+81.4%2021-03-08, Balance as of period end
2018-12-31$73.19M+54.2%2020-07-06, Balance as of period end
2017-12-31$47.46M-31.4%2020-03-17, Balance as of period end
2016-12-31$69.21Mn/c2020-03-17, Balance as of period end
2015-12-31$27.93M+40.1%2017-03-01, Balance as of period end
2014-12-31$19.93M+79.1%2017-02-22, Balance as of period end
2013-12-31$11.13M-26.7%2015-03-13, Balance as of period end
2012-12-31$15.18M-0.2%2014-03-04, Balance as of period end
2011-12-31$15.20Mn/m2013-03-15, Balance as of period end
2010-12-31$1.25Mn/a2012-03-29, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Mimedx Group, Inc. (MDXG)2025-12-31$86.11M+21.6%
Accuray Inc (ARAY)2026-06-30$401.98M+3.3%
Artivion, Inc. (AORT)2025-12-31$436.56M-14.9%
Glaukos Corp (GKOS)2025-12-31$237.33M+14.2%
Tactile Systems Technology Inc (TCMD)2025-12-31$55.04M-32.3%
AtriCure, Inc. (ATRC)2025-12-31$162.24M+9.4%
Angiodynamics Inc (ANGO)2026-05-31$96.34M-0.9%
Bioventus Inc. (BVS)2025-12-31$455.11M-16.1%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$142.21M+7.9%

Compare MDXG, ARAY, AORT, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗